170 related articles for article (PubMed ID: 36211430)
41. Rethinking Immunological Risk: A Retrospective Cohort Study of Severe SARS-Cov-2 Infections in Individuals With Congenital Immunodeficiencies.
Nguyen AA; Habiballah SB; LaBere B; Day-Lewis M; Elkins M; Al-Musa A; Chu A; Jones J; Fried AJ; McDonald D; Hoytema van Konijnenburg DP; Rockowitz S; Sliz P; Oettgen HC; Schneider LC; MacGinnitie A; Bartnikas LM; Platt CD; Ohsumi TK; Chou J
J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3391-3399.e3. PubMed ID: 37544429
[TBL] [Abstract][Full Text] [Related]
42. Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.
Leidi A; Koegler F; Dumont R; Dubos R; Zaballa ME; Piumatti G; Coen M; Berner A; Darbellay Farhoumand P; Vetter P; Vuilleumier N; Kaiser L; Courvoisier D; Azman AS; Guessous I; Stringhini S;
Clin Infect Dis; 2022 Mar; 74(4):622-629. PubMed ID: 34043763
[TBL] [Abstract][Full Text] [Related]
43. Acute and long-term immune responses to SARS-CoV-2 infection in unvaccinated children and young adults with inborn errors of immunity.
García-García A; Fortuny C; Fumadó V; Jordan I; Ruiz-López L; González-Navarro EA; Egri N; Esteve-Solé A; Luo Y; Vlagea A; Cabedo MM; Launes C; Soler A; Codina A; Juan M; Pascal M; Deyà-Martínez A; Alsina L
Front Immunol; 2023; 14():1084630. PubMed ID: 36742319
[TBL] [Abstract][Full Text] [Related]
44. How to Identify Common Variable Immunodeficiency Patients Earlier: General Practice Patterns.
Ilkjær FV; Rasmussen LD; Martin-Iguacel R; Westh L; Katzenstein TL; Hansen AE; Nielsen TL; Larsen CS; Johansen IS
J Clin Immunol; 2019 Oct; 39(7):641-652. PubMed ID: 31372799
[TBL] [Abstract][Full Text] [Related]
45. Mortality and clinical outcomes following SARS-CoV-2 infection among individuals with haematological malignancies: A Danish population-based cohort study.
Lund LC; Rahbek MT; Brown P; Obel N; Hallas J; Frederiksen H
Eur J Haematol; 2023 Dec; 111(6):946-950. PubMed ID: 37740535
[TBL] [Abstract][Full Text] [Related]
46. SARS-CoV-2 in first trimester pregnancy: a cohort study.
la Cour Freiesleben N; Egerup P; Hviid KVR; Severinsen ER; Kolte AM; Westergaard D; Fich Olsen L; Prætorius L; Zedeler A; Christiansen AH; Nielsen JR; Bang D; Berntsen S; Ollé-López J; Ingham A; Bello-Rodríguez J; Storm DM; Ethelberg-Findsen J; Hoffmann ER; Wilken-Jensen C; Jørgensen FS; Westh H; Jørgensen HL; Nielsen HS
Hum Reprod; 2021 Jan; 36(1):40-47. PubMed ID: 33145598
[TBL] [Abstract][Full Text] [Related]
47. Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study.
Kildegaard H; Lund LC; Højlund M; Stensballe LG; Pottegård A
BMJ; 2022 Apr; 377():e068898. PubMed ID: 35410884
[TBL] [Abstract][Full Text] [Related]
48. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
[TBL] [Abstract][Full Text] [Related]
49. COVID-19 infection in CVID patients: What we know so far.
Weifenbach N; Jung A; Lötters S
Immun Inflamm Dis; 2021 Sep; 9(3):632-634. PubMed ID: 33979068
[TBL] [Abstract][Full Text] [Related]
50. Clinical Outcomes, Immunogenicity, and Safety of BNT162b2 Vaccine in Primary Antibody Deficiency.
Milota T; Smetanova J; Skotnicova A; Rataj M; Lastovicka J; Zelena H; Parackova Z; Fejtkova M; Kanderova V; Fronkova E; Rejlova K; Sediva A; Kalina T
J Allergy Clin Immunol Pract; 2023 Jan; 11(1):306-314.e2. PubMed ID: 36379409
[TBL] [Abstract][Full Text] [Related]
51. SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best.
Salinas AF; Mortari EP; Terreri S; Quintarelli C; Pulvirenti F; Di Cecca S; Guercio M; Milito C; Bonanni L; Auria S; Romaggioli L; Cusano G; Albano C; Zaffina S; Perno CF; Spadaro G; Locatelli F; Carsetti R; Quinti I
J Clin Immunol; 2021 Nov; 41(8):1709-1722. PubMed ID: 34669144
[TBL] [Abstract][Full Text] [Related]
52. Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.
Goudouris ES; Pinto-Mariz F; Mendonça LO; Aranda CS; Guimarães RR; Kokron C; Barros MT; Anísio F; Alonso MLO; Marcelino F; Valle SOR; Junior SD; Barreto IDP; Ferreira JFS; Roxo-Junior P; do Rego Silva AM; Campinhos FL; Bonfim C; Loth G; Fernandes JF; Garcia JL; Capelo A; Takano OA; Nadaf MIV; Toledo EC; Cunha LAO; Di Gesu RSW; Schidlowski L; Fillipo P; Bichuetti-Silva DC; Soldateli G; Ferraroni NR; de Oliveira Dantas E; Pestana S; Mansour E; Ulaf RG; Prando C; Condino-Neto A; Grumach AS
J Clin Immunol; 2021 Oct; 41(7):1479-1489. PubMed ID: 34164762
[TBL] [Abstract][Full Text] [Related]
53. T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency - a 22-month follow-up.
Hurme A; Jalkanen P; Marttila-Vaara M; Heroum J; Jokinen H; Vara S; Liedes O; Lempainen J; Melin M; Julkunen I; Kainulainen L
Front Immunol; 2023; 14():1146500. PubMed ID: 37234151
[TBL] [Abstract][Full Text] [Related]
54. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study.
Lund LC; Hallas J; Nielsen H; Koch A; Mogensen SH; Brun NC; Christiansen CF; Thomsen RW; Pottegård A
Lancet Infect Dis; 2021 Oct; 21(10):1373-1382. PubMed ID: 33984263
[TBL] [Abstract][Full Text] [Related]
55. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
56. SARS-CoV-2 and risk of psychiatric hospital admission and use of psychopharmaceuticals: A nationwide registry study of 4,585,083 adult Danish citizens.
Rømer V; Sivapalan P; Eklöf J; Nielsen SD; Harboe ZB; Biering-Sørensen T; Itenov T; Jensen JS
Eur Psychiatry; 2023 Jun; 66(1):e50. PubMed ID: 37282564
[TBL] [Abstract][Full Text] [Related]
57. Missed Opportunities to Diagnose Common Variable Immunodeficiency: a Population-Based Case-Control Study Identifying Indicator Diseases for Common Variable Immunodeficiency.
Dahl C; Petersen I; Ilkjær FV; Westh L; Katzenstein TL; Hansen AE; Nielsen TL; Larsen CS; Johansen IS; Rasmussen LD
J Clin Immunol; 2023 Nov; 43(8):2104-2114. PubMed ID: 37770805
[TBL] [Abstract][Full Text] [Related]
58. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark.
Hansen CH; Friis NU; Bager P; Stegger M; Fonager J; Fomsgaard A; Gram MA; Christiansen LE; Ethelberg S; Legarth R; Krause TG; Ullum H; Valentiner-Branth P
Lancet Infect Dis; 2023 Feb; 23(2):167-176. PubMed ID: 36270311
[TBL] [Abstract][Full Text] [Related]
59. Immunizing the imperfect immune system: Coronavirus disease 2019 vaccination in patients with inborn errors of immunity.
Durkee-Shock JR; Keller MD
Ann Allergy Asthma Immunol; 2022 Nov; 129(5):562-571.e1. PubMed ID: 35718282
[TBL] [Abstract][Full Text] [Related]
60. Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study.
Milota T; Sobotkova M; Smetanova J; Bloomfield M; Vydlakova J; Chovancova Z; Litzman J; Hakl R; Novak J; Malkusova I; Hanzlikova J; Jilek D; Hutyrova B; Novak V; Krcmova I; Sediva A; Kralickova P
Front Immunol; 2022; 13():835770. PubMed ID: 35296097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
